Does downregulation of SIRT4 Expression be Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma?
SIRT4 is a potential prognostic biomarker in ESCC.
COX-2 expression has shown a significant correlation with tumor stage and hence is assumed to be a prognostic factor in our cohort of colorectal cancer patients.